Global Market Study on Neurostimulation Devices: Deep Brain Stimulation Devices to Witness Highest Growth by 2020


  • Published On : May-2015 |
  • Pages : 98 Pages |
  • Format :

Neurology is a branch of medical science that deals with the diagnosis and treatment of diseases of central nerves system (CNS), autonomic nerves system (ANS), and peripheral nervous system (PNS) through medications and neurostimulation devices. A neurostimulation device delivers mild electronic signals to the nervous system, which develop tingling sensations (paresthesia) in the damaged nerve and helps in the treatment of chronic pain and neurological disorders.

The increasing prevalence of chronic pain and rising incidences of neurological diseases are some major drivers of the global neurostimulation devices market. Moreover, rising awareness about various neurological diseases, growing geriatric population, and increasing investments in research and development of innovative neurostimulation devices are also supporting the growth of this market. However, availability of alternative treatment therapies for neurological diseases and side-effects of neurostimulation therapy are some of the major restraints for the global neurostimulation devices market.

In terms of geography, North America dominates the neurostimulation devices market owing to increasing prevalence of various neurological diseases and various initiatives taken by private and government organizations to raise awareness about chronic pain and neurological disorders in the region. Furthermore, technological advancements in neurostimulation devices are also supporting the growth of the neurostimulation devices market in the region. In Europe, the neurostimulation devices market is growing due to initiatives taken by various government organizations to improve healthcare services in the region. In addition, increasing the prevalence of chronic pain and neurological disorders and growing aging population are also supporting the growth of this market in the region. 

Asia Pacific represents the fastest-growing neurostimulation devices market due to growing incidence of chronic pain due to conditions such as osteoporosis and arthritis, in various countries such as China and Japan.

This report provides in-depth analysis and estimation of the neurostimulation devices market for the period 2014 – 2020, considering 2014 as the base year for the calculation. Moreover, data pertaining to current market dynamics, including market drivers, restraints, and recent developments, has been provided in the report. The neurostimulation devices market is categorized on the basis of various types of device, application, and geography. Based on the type of device, the market comprises implantable stimulation devices and external stimulation devices. The implantable stimulation device segment is further sub-segmented into spinal cord stimulation (SCS), deep brain stimulation (DBS), sacral nerve stimulation (SNS), vagus nerve stimulation (VNS), cochlear implants (CI), gastric electric stimulation (GES), and others. The external stimulation device segment includes transcutaneous electrical nerve stimulation (TENS), transcranial magnetic stimulation (TMS), and others. Based on the application, the market covers pain management, depression, Parkinson’s disease, urinary and fecal incontinence, epilepsy, hearing loss, gastroparesis, and others. On the basis of geography, the neurostimulation devices market report identifies and analyzes the market size and forecast for North America, Europe, Asia-Pacific, and Rest of the World (RoW).

Neurology is a branch of medical science that deals with the diagnosis and treatment of diseases of central nerves system (CNS), autonomic nerves system (ANS), and peripheral nervous system (PNS) through medications and neurostimulation devices. 

A neurostimulation device delivers mild electronic signals to the nervous system, which develops tingling sensations (paresthesia) in the damaged nerve and helps in the treatment of chronic pain and neurological disorders.

The global neurostimulation devices market is witnessing significant growth due to increasing prevalence of chronic pain and rising incidences of neurological diseases. Moreover, rising awareness about various neurological diseases, growing geriatric population, and increasing investments in research and development of innovative neurostimulation devices are the other factors driving the market. However, availability of alternative treatment therapies for neurological diseases and side-effects of neurostimulation therapy inhibits the growth of the market. 

The global neurostimulation devices market is anticipated to grow from an estimated US$ 5,088.9 Mn in 2014 to US$ 10,445.7 Mn by 2020 at a CAGR of 12.7% during the forecast period.

North America is the largest market, while Asia Pacific represents the fastest-growing market for neurostimulation devices. Spinal cord stimulation (SCS) represents the largest segment, while deep brain stimulation (DBS) is the fastest-growing implantable neurostimulation device sub-segment in the market. Transcutaneous electrical nerve stimulation (TENS) is the largest and fastest-growing external device sub-segment in the market. In terms of application, pain management represents the largest and fastest-growing application segment in the neurostimulation devices market. 

The neurostimulation devices market in North America is anticipated to grow from an estimated US$ 2,449.9 Mn in 2014 to US$ 4,892.9 Mn by 2020 at a CAGR of 12.2% during the forecast period.

Some of the major players in the neurostimulation devices market:

  • Medtronic plc, St. Jude Medical, Inc.
  • Boston Scientific Corporation.
  • Cyberonics, Inc.
  • Cochlear, Ltd.
  • NDI Medical, LLC.
  • NeuroPace, Inc.
  • MED-EL.
  • NeuroSigma, Inc.
  • Other.

These key market players have been profiled on the basis of attributes such as company overview, recent developments, growth strategies, sustainability, and financial overview.

Chapter 1Preface11

1.1Report Description11

1.2Research Methodology12

1.3Assumptions13

Chapter 2Market Synopsis14

Chapter 3Porter’s Five Forces Analysis16

3.1Bargaining Power of Suppliers16

3.2Bargaining Power of Buyers17

3.3Threat of New Entrants17

3.4Threat of Substitutes17

3.5Intensity of Rivalry18

Chapter 4Industry Overview19

4.1Market Definition19

4.2Market Drivers20

     4.2.1Increasing prevalence of chronic pain20

     4.2.2Rise in incidence of neurological disorders21

4.2.3Rising awareness about mental diseases and their treatment21

     4.2.4Growing aging population22

     4.2.5Increasing R&D investments in novel and innovative neurostimulation devices developments23

     4.2.6Increasing demand for minimally invasive treatment24

4.3Impact Analysis of Market Drivers25

4.4Market Restraints26

     4.4.1Availability of alternative treatment therapies for neurological diseases26

     4.4.2Side-effects of neurostimulation devices26

4.5Impact Analysis of Market Restraints27

4.6Opportunities27

     4.6.1Emerging markets hold major potential27

Chapter 5Global Market Size and Forecast28

Chapter 6Market Size and Forecast, by Device Type39

6.1Implantable device39

6.2External devices41

Chapter 7Market Size and Forecast, by Implantable Devices44

7.1Spinal Cord Stimulation44

7.2Deep Brain Stimulation46

7.3Sacral Nerve Strimulation48

7.4Vagus Nerve Stimulation50

7.5Cochlear Implants52

7.6Gastric Electric Stimulation54

Chapter 8Market Size and Forecast, by External Devices57

8.1Transcutaneous Electrical Nerve Stimulation57

8.2Transcranial Magnetic Stimulation59

Chapter 9Market Size and Forecast, by Application62

9.1Pain Management62

9.2Parkinson’s Disease64

9.3Urinary and Fecal Incontinence66

9.4Epilepsy68

9.5Hearing loss70

9.6Gastroparesis72

9.7Depression74

Chapter 10Market Size and Forecast, by Geography77

10.1North America77

10.2Europe80

10.3Asia Pacific83

10.4Rest of the World (RoW)85

Chapter 11Competitive Scenario88

11.1Competitive Benchmarking88

Chapter 12Company Profiles91

12.1Medtronic plc91

     12.1.1Company overview91

     12.1.2Products and services92

     12.1.3Financial performance93

     12.1.4Key developments93

12.2St. Jude Medical, Inc.94

     12.2.1Company overview94

     12.2.2Products and services94

     12.2.3Financial performance95

     12.2.4Key developments95

12.3Boston Scientific Corporation96

     12.3.1Company overview96

     12.3.2Products and services97

     12.3.3Financial performance98

     12.3.4Key developments98

12.4Cyberonics, Inc.99

     12.4.1Company overview99

     12.4.2Products and services99

     12.4.3Financial performance100

     12.4.4Key developments100

12.5Cochlear, Ltd.101

     12.5.1Company overview101

     12.5.2Products and services101

     12.5.3Financial performance102

     12.5.4Key developments102

12.6NeuroPace, Inc.103

     12.6.1Company overview103

     12.6.2Products and services103

     12.6.3Financial performance103

     12.6.4Key developments104

12.7NeuroSigma, Inc.105

     12.7.1Company overview105

     12.7.2Products and services105

     12.7.3Financial performance105

     12.7.4Key developments106

12.8NDI Medical, LLC107

     12.8.1Company overview107

     12.8.2Products and services107

     12.8.3Financial performance107

     12.8.4Key developments108

12.9MED-EL109

     12.9.1Company overview109

     12.9.2Products and services109

     12.9.3Financial performance110

     12.9.4Key developments110


List of Tables

TABLE 1Market snapshot: Neurostimulation devices market, 2014 and 202014

TABLE 2Drivers for neurostimulation devices market: Impact analysis25

TABLE 3Restraints for neurostimulation devices market: Impact analysis27

TABLE 4Global neurostimulation devices market size, by region, 2010 – 2013 (USD million)29

TABLE 5Global neurostimulation devices market size, by region, 2014 – 2020 (USD million)29

TABLE 6Global neurostimulation devices market size, by type of devices, 2010 – 2013 (USD million)30

TABLE 7Global neurostimulation devices market size, by type of device, 2014 – 2020 (USD million)31

TABLE 8Global neurostimulation devices market, by implantable devices, 2010 – 2013 (USD million)32

TABLE 9Global neurostimulation devices market, by implantable devices, 2014 – 2020 (USD million)33

TABLE 10Global neurostimulation devices market, by external devices, 2010 – 2013 (USD million)34

TABLE 11Global neurostimulation devices market, by external device type, 2014 – 2020 (USD million)35

TABLE 12Global neurostimulation devices market, by application type, 2010 – 2013 (USD million)37

TABLE 13Global neurostimulation devices market, by application type, 2014 – 2020 (USD million)38

TABLE 14Global implantable device market size, by region, 2010 – 2013 (USD million)40

TABLE 15Global implantable devices market size, by region, 2014 – 2020 (USD million)41

TABLE 16Global external devices market size, by region, 2010 – 2013 (USD million)42

TABLE 17Global external devices market size, by region, 2014 – 2020 (USD million)43

TABLE 18Global SCS market size, by region, 2010 – 2013 (USD million)45

TABLE 19Global SCS market size, by region, 2014 – 2020 (USD million)45

TABLE 20Global DBS market size, by region, 2010 – 2013 (USD million)47

TABLE 21Global DBS market size, by region, 2014 – 2020 (USD million)48

TABLE 22Global SNS market size, by region, 2010 – 2013 (USD million)49

TABLE 23Global SNS market size, by region, 2014 – 2020 (USD million)50

TABLE 24Global VNS market size, by region, 2010 – 2013 (USD million)51

TABLE 25Global VNS market size, by region, 2014 – 2020 (USD million)52

TABLE 26Global CI market size, by region, 2010 – 2013 (USD million)53

TABLE 27Global CI market size, by region, 2014 – 2020 (USD million)54

TABLE 28Global GES market size, by region, 2010 – 2013 (USD million)55

TABLE 29Global GES market size, by region, 2014 – 2020 (USD million)56

TABLE 30Global TENS market size, by region, 2010 – 2013 (USD million)58

TABLE 31Global TENS market size, by region, 2014 – 2020 (USD million)58

TABLE 32Global TMS market size, by region, 2010 – 2013 (USD million )60

TABLE 33Global TMS market size, by region, 2014 – 2020 (USD million)60

TABLE 34Global pain management market size, by region, 2010 – 2013 (USD )63

TABLE 35Global pain management market size, by region, 2014 – 2020 (USD million)64

TABLE 36Global Parkinson’s disease market size, by region, 2010 – 2013 (USD million)65

TABLE 37Global Parkinson’s disease market size, by region, 2014 – 2020 (USD million)66

TABLE 38Global urinary and fecal incontinence market size, by region, 2010 – 2013 (USD million)67

TABLE 39Global urinary and fecal incontinence market size, by region, 2014 – 2020 (USD million)68

TABLE 40Global epilepsy market size, by region, 2010 – 2013 (USD million)69

TABLE 41Global epilepsy market size, by region, 2014 – 2020 (USD million)70

TABLE 42Global hearing loss market size, by region, 2010 – 2013 (USD million)71

TABLE 43Global hearing loss market size, by region, 2014 – 2020 (USD million)72

TABLE 44Global gastroparesis market size, by region, 2010 – 2013 (USD million)73

TABLE 45Global gastroparesis market size, by region, 2014 – 2020 (USD million)74

TABLE 46Global depression market size, by region, 2010 – 2013 (USD million)75

TABLE 47Global depression market size, by region, 2014 – 2020 (USD million)76

TABLE 48North America neurostimulation devices market size, by country, 2010 – 2013 (USD million)79

TABLE 49North America neurostimulation devices market size, by country, 2014 – 2020 (USD million)80

TABLE 50Europe neurostimulation devices market size, by country, 2010 – 2013 (USD million)82

TABLE 51Europe neurostimulation devices market size, by country, 2014 – 2020 (USD million)82

TABLE 52Asia Pacific neurostimulation devices market size, by country, 2010 – 2013 (USD million)84

TABLE 53Asia Pacific neurostimulation devices market size, by country, 2014 – 2020 (USD million)85

TABLE 54RoW neurostimulation devices market size, by country, 2010 – 2013 (USD million)86

TABLE 55RoW neurostimulation devices market size, by country, 2014 – 2020 (USD million)87

TABLE 56Product categories of Medtronic plc92

TABLE 57Product categories of St. Jude Medical, Inc94

TABLE 58Product categories of Boston Scientific Corporation97

TABLE 59Product categories of Cyberonics, Inc99

TABLE 60Product categories of Cochlear, Ltd.101

TABLE 61Product categories NeuroPace, Inc.103

TABLE 62Product categories of NeuroSigma, Inc.105

TABLE 63Product categories of NDI Medical, LLC107

TABLE 64Product categories of MED-EL109


List of Figures 

FIG. 1Neurostimulation devices market: Porter’s five forces analysis16

FIG. 2Aging population in major countries, 2000 – 2050 (% share of total population)23

FIG. 3Global neurostimulation devices market share, by region, by value, 201328

FIG. 4Global neurostimulation devices market share, by type of devices, by value, 201330

FIG. 5Global neurostimulation devices market share, by implantable devices, by value, 201331

FIG. 6Global neurostimulation devices market share, by external devices, by value, 201334

FIG. 7Global neurostimulation devices market share, by application type, by value, 201336

FIG. 8Global implantable device market share, by region, by value, 201339

FIG. 9Global external devices market share, by region, by value, 201342

FIG. 10Global SCS market share, by region, by value 201344

FIG. 11Global DBS market, by region 2013 (% share)47

FIG. 12Global SNS market share, by region, by value 201349

FIG. 13Global VNS market share, by region, by value, 2013 (% share)51

FIG. 14Global CI market share, by region, by value, 2013 (% share)53

FIG. 15Global GES market share, by region, by value, 2013 (% share)55

FIG. 16Global TENS market share, by region, by value, 2013 (% share)57

FIG. 17Global TMS market share, by region, by value, 201359

FIG. 18Global pain management market share, by region, by value, 201362

FIG. 19Global Parkinson’s disease market share, by region, by value, 201365

FIG. 20Global urinary and fecal incontinence market share, by region, by value, 201367

FIG. 21Global epilepsy market share, by region, by value, 201369

FIG. 22Global hearing loss market share, by region, by value, 201371

FIG. 23Global gastroparesis market share, by region, by value, 201373

FIG. 24Global depression market share, by region, by value, 201375

FIG. 25North America neurostimulation devices market share, by country, by value, 2013 (% share)79

FIG. 26Europea neurostimulation devices market share, by country, by value, 2013 (% share)81

FIG. 27Asia Pacific neurostimulation devices market share, by country, by value, 2013 (% share)84

FIG. 28RoW neurostimulation devices market share, by country, by value, 2013 (% share)86

FIG. 29Leading players and their product offerings in the market88

FIG. 30Overall market presence and focus on neurostimulation business89

FIG. 31Sales and net earnings of Medtronic, plc, 2012 – 2014 (USD Million)93

FIG. 32Net sales and net earnings of St. Jude Medical, Inc, 2011 – 2013 (USD Million)95

FIG. 33Net sales and net income/loss of Boston Scientific Corporation, 2011 – 2013 (USD Million)98

FIG. 34Net sales and net income of Cyberonics, Inc, 2011 – 2013 (USD Million)100

FIG. 35Revenue and net profit of Cochlear, Ltd., 2011 – 2013 (USD million)102

Back To Top